Hjorth, M., Axelsson, S., Rydén, A., Faresjö, M., Ludvigsson, J., & Casas, R. (2011). GAD-alum treatment induces GAD65-specific CD4+CD25highFOXP3+ cells in type 1 diabetic patients. Clinical immunology (Orlando, Fla.), 138(1), 117. https://doi.org/10.1016/j.clim.2010.10.004
Style de citation ChicagoHjorth, Maria, Stina Axelsson, Anna Rydén, Maria Faresjö, Johnny Ludvigsson, et Rosaura Casas. "GAD-alum Treatment Induces GAD65-specific CD4+CD25highFOXP3+ Cells in Type 1 Diabetic Patients." Clinical Immunology (Orlando, Fla.) 138, no. 1 (2011): 117. https://dx.doi.org/10.1016/j.clim.2010.10.004.
Style de citation MLAHjorth, Maria, et al. "GAD-alum Treatment Induces GAD65-specific CD4+CD25highFOXP3+ Cells in Type 1 Diabetic Patients." Clinical Immunology (Orlando, Fla.), vol. 138, no. 1, 2011, p. 117.